This ETF is trying to satisfy appetites for weight loss stocks
Tema ETFs has been capitalizing on the risk appetite for weight loss stocks.It is behind the GLP-1, Obesity & Cardiometabolic ...
Tag: Health care industry
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
Kena Betancur | Corbis News | Getty ImagesPfizer had a "phenomenal" first quarter — and Wall Street took notice, CEO ...
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of the most ...
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections
Zoom In IconArrows pointing outwardsMerck's new pneumococcal vaccine. Courtesy: MerckThe Food and Drug Administration on Monday approved Merck's new vaccine ...
Google-backed Tempus AI closes first day of trading up 9% in Nasdaq stock market debut
Tempus AI, a health-care diagnostics company that uses AI to interpret medical tests to help physicians provide more accurate treatment ...
Moderna’s combination Covid, flu vaccine is more effective than existing shots in late-stage trial
Empty bottles of Moderna's Covid-19 vaccine.Fred Tanneau | AFP | Getty ImagesModerna on Monday said its combination vaccine that targets ...
FDA approves GSK’s RSV vaccine for high-risk adults ages 50 to 59, expanding shot’s reach
A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022.Hannah Mckay | ReutersThe Food and Drug Administration on Friday ...
The Covid-19 pandemic worsened a child care crisis, and it’s costing U.S. businesses billions
Vadym Buinov | Moment | Getty ImagesThe Covid-19 pandemic brought to the surface both cracks and resilience in the American ...
Waystar shares slip in Nasdaq debut after digital health company priced IPO in middle of range
Waystar celebrates its IPO at the Nasdaq, June 7, 2024.CNBCWaystar shares slid about 3% in their Nasdaq debut on Friday, ...
Pfizer’s drug for advanced lung cancer shows promising long-term trial results
CHICAGO — Pfizer on Friday said its drug for an advanced form of lung cancer showed promising long-term results in ...
